With The Honest Difference®, Pet Honesty is doubling down on its commitment to provide the rigorous scientific validation, testing, and clean ingredients required to deliver real, noticeable results...
The purpose of this study was to enhance the current knowledge of the relationship between the gut microbiome and osteoarthritis (OA) and associated pain using pet dogs as a clinically relevant...
Undergraduate students in Washington State University’s College of Veterinary Medicine helped power the research behind a recent Nature publication that found humans share key skin structures...
Phibro Animal Health Corporation (Nasdaq: PAHC) today announced the launch of its new Sustainable Solutions Platform (SSP), a companywide initiative designed to help animal protein, dairy and petfood...
Feline gastrointestinal eosinophilic sclerosing fibroplasia (FGESF) is a rare and poorly understood disease characterised by the infiltration of eosinophils and the development of fibrous tissue...
Antimicrobial resistance (AMR) is one of the main health concerns worldwide and addressing the problem through the One Health approach is essential to manage the burden of AMR emergence and...
Carcinoma in situ of the breast is a well-known entity in humans. In veterinary medicine, particularly in canine and feline mammary literature, there is no agreement whether the term in situ should...
Lameness due to musculoskeletal disease is the most common diagnosis in equine veterinary practice. Many of these orthopaedic disorders are chronic problems, for which no clinically satisfactory...
The AQUAVET® I program provides valuable hands-on experience in aquatic veterinary medicine to fill a critical gap in traditional veterinary curricula.
Phibro Animal Health Corporation (Nasdaq: PAHC) today announced expected implementation of a new regulatory framework governing the use of certain antimicrobials in Brazil that have growth promotion...
